Oncomedicine 2016; 1:18-24. doi:10.7150/oncm.16928 This volume Cite

Review

Head and Neck Cancer Therapy from Bench to Bedside

Ilias Karapantzos1, Paul Zarogoulidis2✉, Michail Karanikas3, Vasilis Thomaidis4, Charalampos Charalampidis5, Chrysa Karapantzou1

1. Ear, Nose and Throat Department, “Saint Luke” Private Hospital, Panorama, Thessaloniki, Greece
2. Pulmonary Department-Oncology Unit, “G. Papanikolaou” General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
3. General Surgery Department, “Genisis” Private Clinic, Thessaloniki, Greece
4. Department of Maxillofacial Surgery, University General Hospital of Alexandroupolis, Alexandroupolis, Greece
5. Department of Anatomy, Democritus University of Thrace, Alexandroupolis, Greece.

Citation:
Karapantzos I, Zarogoulidis P, Karanikas M, Thomaidis V, Charalampidis C, Karapantzou C. Head and Neck Cancer Therapy from Bench to Bedside. Oncomedicine 2016; 1:18-24. doi:10.7150/oncm.16928. http://www.oncm.org/v01p0018.htm
Other styles

File import instruction

Abstract

Nowadays treatment of laryngeal and hypopharyngel cancer is not defined only by surgical resection. Multimodality treatment approach is considered the best approach for patients. Currently treatment includes chemotherapy, radiotherapy, and surgery. The goal with combination treatment approach is to preserve organ and function. In the past years unfortunately we had to deal with mutilating and function destroying treatment. In the past 25 years, evidences from large randomized trials presented data that organ preservation studies using sequential and concomitant radio-chemotherapy do not compromise survival when compared with surgery followed by radiotherapy. The side effects from multimodality treatment approach has to take into account and the final goal has to be not only organ preservation but also function preservation. In the current review we focus on the most common treatment options. We conclude that there is an urgent need to refine the definition of a functional organ and to refine recommendations for evaluating treatment response.

Keywords: Head and neck cancer, Concurrent radio-chemotherapy, Induction chemotherapy, Organ preservation surgery, Molecular therapy


Citation styles

APA
Karapantzos, I., Zarogoulidis, P., Karanikas, M., Thomaidis, V., Charalampidis, C., Karapantzou, C. (2016). Head and Neck Cancer Therapy from Bench to Bedside. Oncomedicine, 1, 18-24. https://doi.org/10.7150/oncm.16928.

ACS
Karapantzos, I.; Zarogoulidis, P.; Karanikas, M.; Thomaidis, V.; Charalampidis, C.; Karapantzou, C. Head and Neck Cancer Therapy from Bench to Bedside. Oncomedicine 2016, 1, 18-24. DOI: 10.7150/oncm.16928.

NLM
Karapantzos I, Zarogoulidis P, Karanikas M, Thomaidis V, Charalampidis C, Karapantzou C. Head and Neck Cancer Therapy from Bench to Bedside. Oncomedicine 2016; 1:18-24. doi:10.7150/oncm.16928. http://www.oncm.org/v01p0018.htm

CSE
Karapantzos I, Zarogoulidis P, Karanikas M, Thomaidis V, Charalampidis C, Karapantzou C. 2016. Head and Neck Cancer Therapy from Bench to Bedside. Oncomedicine. 1:18-24.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.